Machine Learning (ML) in The Pharmaceutical Industry Market Report 2026

Machine Learning (ML) in The Pharmaceutical Industry Market Overview

• Machine Learning (ML) in The Pharmaceutical Industry market size has reached to $4.08 billion in 2025 • Expected to grow to $18.71 billion in 2030 at a compound annual growth rate (CAGR) of 35.7% • Growth Driver: Transformative Role Of Artificial Intelligence (AI) And Machine Learning (ML) In The Pharmaceutical Industry • Market Trend: Cutting-Edge AI-Integrated Platforms Unveiled By Major Players In The Pharmaceutical Industry • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Machine Learning (ML) in The Pharmaceutical Industry Market?

Machine learning (ML) in the pharmaceutical industry market refers to the use of artificial intelligence (AI) algorithms and techniques. They are used to improve various aspects of drug discovery, development, and manufacturing processes. The implementation of ML solutions in the pharmaceutical industry requires careful regulatory compliance and addressing potential challenges related to data quality, research gaps, and regulatory uncertainty. The main components of machine learning (ML) in the pharmaceutical industry are solutions and services. Solution refers to an application or system that leverages machine learning algorithms and techniques to address specific challenges or tasks within the pharmaceutical domain, its deployments include cloud, and on-premise, and it has enterprises sized such as small and medium enterprises (SMEs), and large enterprises.

What Is The Machine Learning (ML) in The Pharmaceutical Industry Market Growth Forecast?

The machine learning (ml) in the pharmaceutical industry market size is expected to see exponential growth in the next few years. It will grow to $18.71 billion in 2030 at a compound annual growth rate (CAGR) of 35.7%. The growth in the forecast period can be attributed to growing integration of ai in clinical trials, expansion of precision medicine, increasing use of real-world data analytics, advancement in cloud-based pharmaceutical platforms, development of personalized therapeutics. Major trends in the forecast period include predictive drug discovery models, clinical trial optimization, real-world evidence data utilization, personalized medicine implementation, regulatory compliance automation.

Global Machine Learning (ML) in The Pharmaceutical Industry Market Segmentation

1) By Component: Solution, Services 2) By Deployment: Cloud, On-premise 3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises Subsegments: 1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications 2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services

What Is The Driver Of The Machine Learning (ML) in The Pharmaceutical Industry Market?

The increasing adoption of artificial intelligence (AI) is driving machine learning (ML) in the pharmaceutical industry. AI is computer software that mimics human cognition to perform complex tasks, such as analyzing, reasoning, and learning, while ML is a subset of AI that uses algorithms trained on data to produce models that can perform complex tasks. AI and ML has been utilized in pharmaceutical technology and drug delivery design, offering expedited solutions to complex challenges. It has the potential to transform the drug delivery process, enhance decision-making tools, and handle large quantities of data for a more effective decision. For instance, in June 2023, according to Forbes, a US-based business magazine, approximately 432,000 UK organizations, or one in six, have adopted at least one AI technology. Further, at least one AI technology has been adopted by 68% of large businesses, 33% of medium-sized businesses, and 15% of small businesses. Therefore, the increasing adoption of artificial intelligence (AI) will drive machine learning (ML) in the pharmaceutical industry.

Key Players In The Global Machine Learning (ML) in The Pharmaceutical Industry Market

Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs

Global Machine Learning (ML) in The Pharmaceutical Industry Market Trends and Insights

Major companies operating in machine learning (ML) in the pharmaceutical industry are focusing on developing user-friendly software platforms, such as drug discovery software, to improve their drug discovery capabilities. Drug discovery software is a broad term encompassing a variety of specialized tools and platforms used throughout the process of identifying and developing new pharmaceutical drugs. For instance, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, launched the AIDDISON drug discovery software, which is the first software-as-a-service platform that integrates drug discovery and synthesis using generative AI, machine learning, and computer-aided drug design. This platform enables laboratories to identify suitable drug candidates in a vast chemical space, virtually screen compounds from a universe of over 60 billion chemical targets, and evaluate synthesis routes for safer, more cost-effective, and higher-yield drug manufacturing.

What Are Latest Mergers And Acquisitions In The Machine Learning (ML) in The Pharmaceutical Industry Market?

In July 2023, BioNTech SE, a Germany-based biopharmaceutical company, acquired InstaDeep for $541 million. The acquisition is expected to strengthen BioNTech's pioneering position in the field of AI-powered drug discovery, design, and development. InstaDeep, a UK-based technology company, offers a range of AI solutions and machine learning services for the pharmaceutical industry.

Regional Insights

North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Machine Learning (ML) in The Pharmaceutical Industry Market?

The machine learning (ML) in the pharmaceutical industry market consists of revenues earned by entities by providing components of machine learning (ML) in the pharmaceutical industry market such as solutions and services. The market value includes the value of related goods sold by the service provider or included within the service offering. The machine learning (ML) in the pharmaceutical industry market also includes sales of central processing units (CPUs), random access memory, storage systems, and graphics processing units (GPUs). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Machine Learning (ML) in The Pharmaceutical Industry Market Report 2026?

The machine learning (ml) in the pharmaceutical industry market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the machine learning (ml) in the pharmaceutical industry industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.